Home » News
Posted on 05/11/2008 by
Baldwins Intellectual Property was delighted to once again be a principal sponsor of the recent AmCham-UPS Success and Innovation Awards. Read More
Posted on 03/10/2008 by
The Patents Bill 2008 was introduced into Parliament on 9 July 2008. With an Election imminent in November this year, there is some doubt as to the timeframe for enacting the legislation. Read More
Posted on 02/09/2008
AMCHAM's Digital Future Now forum was an opportunity for nearly 100 senior executives from businesses operating in the online environment to discuss the many challenges and issues impacting the industry. Read More
Posted on 01/09/2008 by
As discussed in Managing IP’s March edition, it was becoming increasingly unclear whether method of diagnosis claims were allowable in New Zealand. Read More
Posted on 14/07/2008
The Patents Bill was introduced to the House of Representatives for its first reading on 9 July 2008. The full text of the Patents Bill is available online. Read More
Posted on 01/06/2008 by
The Intellectual Property Office of New Zealand (IPONZ) recently completed a review of its practice of raising objections based on morality considerations, and has just released new guidelines that may cause difficulties for some biotechnology patent applications. Read More
Posted on 26/05/2008 by
The Intellectual Property Office of New Zealand (IPONZ) recently completed a review of its practice of raising objections based on morality considerations, and has just released new guidelines that may cause difficulties for some biotechnology patent applications. Read More
Posted on 14/12/2007 by
Good news for innovators - amendment due on experimental use exception The Australian government has responded to the recommendations of the Advisory Council on Intellectual Property (ACIP) report, Patents and Experimental Use, and agreed to amend the Patents... Read More
Posted on 01/05/2007 by
The Intellectual Property Office of New Zealand (IPONZ) has just released a decision of particular significance to the pharmaceutical industry. Read More
Posted on 30/11/2006 by
*A patent provides up to a 20 year monopoly in an invention in return for the inventor fully disclosing the invention to the public. When the patent expires, anyone is entitled to exploit the invention. Read More